Company / Depreciation & Amortization
Glaukos Corp. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$38.1M
FY2025
5-year range
$29.7M / $38.1M
FY2021-FY2025
Trend
+6.9%
vs FY2024
Sector context
#84 of 135
Health Care
What the data says
At $38M, Glaukos Corp.'s depreciation & amortization ranks #52 of 135 in the Health Care sector. Depreciation & Amortization has increased for 9 consecutive years, from $5M in FY2016 to $38M in FY2025.
Based on SEC 10-K filings.
$38M in FY2025 with a 5-year CAGR of +5.3%.
Increased from $34M to $38M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Sector benchmark
#52 of 135 in Health CareTop 38% of 135This company $38.1M Sector average $334.5M
▼
-88.6% below sector average
Key checks
Key Insights
- Glaukos Corp.'s depreciation & amortization has grown for 9 consecutive years.
- 5-year CAGR of +5.3%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 6.9% year-over-year.
- Ranks #84 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.1M | +6.9% |
| FY2024 | $35.6M | +5.9% |
| FY2023 | $33.7M | +6.6% |
| FY2022 | $31.6M | +6.5% |
| FY2021 | $29.7M | +1.0% |
| FY2020 | $29.4M | +365.9% |
| FY2019 | $6.3M | +0.7% |
| FY2018 | $6.3M | +14.3% |
| FY2017 | $5.5M | +16.1% |
| FY2016 | $4.7M | +10.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026